Prediction of chemo-response in serous ovarian cancer

BACKGROUND: Nearly one-third of serous ovarian cancer (OVCA) patients will not respond to initial treatment with surgery and chemotherapy and die within one year of diagnosis. If patients who are unlikely to respond to current standard therapy can be identified up front, enhanced tumor analyses and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Cancer
Autori principali: Gonzalez Bosquet, Jesus, Newtson, Andreea M., Chung, Rebecca K., Thiel, Kristina W., Ginader, Timothy, Goodheart, Michael J., Leslie, Kimberly K., Smith, Brian J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070116/
https://ncbi.nlm.nih.gov/pubmed/27756408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-016-0548-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi